OS Therapies Financials - Benzinga

OS Therapies Inc

OSTXAMEX

Trade with Public

Trade with Public

$1.86

0.031.64%

At close: Sep 9, 5:00 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

OS Therapies Financials

OS Therapies (OSTX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Earnings Scheduled For May 18, 2026

Benzinga Insights

PRO
OS Therapies Q1 EPS $(0.27) Misses $(0.18) Estimate

OS Therapies (AMEX:OSTX) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.18) by 50 percent. This is a 50 percent decrease over losses of $(0.18) per share from the same

Benzinga Newsdesk

PRO
OS Therapies Q4 EPS $(0.41) Misses $(0.13) Estimate

OS Therapies (AMEX:OSTX) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.13) by 228 percent. This is a 70.83 percent decrease over losses of $(0.24) per share from the

Benzinga Newsdesk

PRO
OS Therapies Q3 EPS $(0.21) Misses $(0.13) Estimate

Benzinga Newsdesk

PRO
OS Therapies Q2 EPS $(0.19) Misses $(0.12) Estimate

OS Therapies (AMEX:OSTX) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.12) by 65.22 percent. This is a 26.92 percent increase over losses of $(0.26) per share from the

Benzinga Newsdesk

Earnings Outlook For OS Therapies

Benzinga Insights